Irinotecan Fresenius 40 mg/2 ml
Irinotecan Fresenius 40 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 61246. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 January 2011 and the authorisation is valid without a time limit. ATC code L01XX19 places the medicine in the group Antineoplastic agents.
| Authorisation number | 61246 |
|---|---|
| Name | Irinotecan Fresenius 40 mg/2 ml |
| Full name | Irinotecan Fresenius 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Fresenius Kabi (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX19 |
| First authorisation | 28 January 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Irinotecan Fresenius 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 28 January 2011 |
| 2 | Irinotecan Fresenius 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 28 January 2011 |
| 3 | Irinotecan Fresenius 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 28 January 2011 |
| 4 | Irinotecan Fresenius 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 28 January 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 17 | 1 | Durchstechflasche(n) | L01XX19 | 07.16.1. | A |
| 18 | 1 | Durchstechflasche(n) | L01XX19 | 07.16.1. | A |
| 19 | 1 | Durchstechflasche(n) | L01XX19 | 07.16.1. | A |
| 20 | 1 | Durchstechflasche(n) | L01XX19 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Irinotecan Fresenius 40 mg/2 ml authorised in Switzerland?
Yes. Irinotecan Fresenius 40 mg/2 ml is authorised by Swissmedic under authorisation number 61246, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Irinotecan Fresenius 40 mg/2 ml have?
Irinotecan Fresenius 40 mg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Irinotecan Fresenius 40 mg/2 ml?
The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.